Deteriorating beta‐cell function in type 2 diabetes: a long‐term model

Abstract

This model may have important implications for targeting appropriate therapy to patients in each phase: delaying or avoiding full clinical type 2 diabetes in the first phase; and preventing the development of diabetic complications in the second phase.